Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Open accessThe DOI matches its Crossref record.
Abstract
Summary: Purpose: This study investigated the effectiveness of topiramate (TPM) as an inhibitor of six isozymes of carbonic anhydrase (CA). Methods: The inhibition constants (K i) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA). The activity of CA was studied by using purified isozymes, erythrocytes, subcellular fractions of kidney or brain, and saliva, and was assayed at 37°C or 25°C by 18 O mass spectrometry and/or by measuring the pH shift at 0°C. Results: Topiramate K i values for HCA I, HCA II, HCA IV, and HCA VI were ∼100, 7, 10, and >100 μ M, respectively. TPM K i values for RCA I, RCA II, RCA III, RCA IV, and RCA V were ∼180, 0·1 to 1, >100, 0·2 to 10 and 18 μ M, respectively. For RCA II and RCA IV, the K i values were temperature dependent. TPM K i values for MCA II and MCA IV ranged between 1 and 20 μ M. Conclusions: These results indicate that TPM is more potent as an inhibitor of CA II and CA IV than of CA I, CA III, and CA VI. In all three species, AZM was usually 10 to 100 times more potent than TPM as an inhibitor of CA isozymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study
Çelebisoy, N., Gökçay, F., Şirin, H., & Akyürekli, Ö. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00905.x · Cited by 348
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
Rogawski, M. A., Löscher, W., & Rho, J. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022780 · Cited by 336
Migraine: Preventive Treatment
Silberstein, S., & Goadsby, P. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00386.x · Cited by 259
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
Dixon, B., Reis, C., Ho, W., Tang, J., & Zhang, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922368 · Cited by 182
“Its neuroprotective mechanisms appear to be related not only to AMPA and Kainate receptors inhibition [117–119,176,177] but also to blockade of Na+ channels [120], high voltage-activated calcium currents [121], carbonic anhydrase isoenzymes [122], and mitochondrial permeability transition pore [123].”
BackgroundGABAA Receptors in Normal Development and Seizures: Friends or Foes?
Galanopoulou, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769653 · Cited by 156
Metadata
- Authors
- Dodgson, S. J., Shank, R. P., & Maryanoff, B. E.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2000-01
- Volume
- 41
- Issue
- s1
- Pages
- 35-39
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W4243253613
- Cited by
- 150
- References
- 0
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes. https://app.cochat.ai/papers/10.1111/j.1528-1157.2000.tb02169.x
- The paper
- Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000). Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes. Epilepsia. https://doi.org/10.1111/j.1528-1157.2000.tb02169.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.